In the 2019 financial year, the total value of current liabilities of Melbourne-based CSL Limited amounted to over 2.18 billion U.S. dollars. CSL Limited is a global biotechnology company that is involved in the research, development, manufacturing, and marketing of products used to treat human medical conditions.
Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic R&D expenditure of CSL Ltd FY 2015-2022
- Premium Statistic Total operating revenue of CSL Ltd FY 2015-2022
- Premium Statistic Net profit of CSL Ltd FY 2015-2022
- Premium Statistic Earnings per share of CSL Ltd Australia FY 2015-2019
- Premium Statistic Total current assets of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total non current assets of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total non current liabilities of CSL Ltd Australia FY 2014-2019
- Premium Statistic Total equity of CSL Ltd Australia FY 2014-2019
- Premium Statistic Per capita health expenditure in Latin America 2021, by country & type
- Premium Statistic Medical products: Weekly UK household expenditure 2022, by gross income
About the region
10
- Premium Statistic Number of public hospitals in Australia by remoteness and state FY 2019
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2023
- Premium Statistic Deaths caused by diabetes in Australia 2005-2020
- Premium Statistic Rate of type 1 diabetes diagnoses in Australia 2006-2020
- Premium Statistic Subsidized drug expenditure in Australia FY 2016-2022
- Premium Statistic Revenue of Sonic Healthcare Limited FY 2015-2022
- Premium Statistic EBITDA of Sonic Healthcare Limited FY 2015-2022
- Premium Statistic Prevalence of type 2 diabetes in Australia 2020 by age group and gender
- Premium Statistic Most commonly used prescription drugs Australia FY 2023
- Premium Statistic Most prescribed prescription drugs Australia FY 2021, by prescriptions
Other regions
10
- Basic Statistic Leading vaccines and antisera dispensed in England 2022, by item number
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic Biotech enterprises in Spain 2020, by size
- Basic Statistic Opinion on long-term effects of COVID-19 in Russia in 2020
- Basic Statistic Canadian behavior changes in response to coronavirus as of Feb 9, 2020, by action
- Premium Statistic Projection of top orphan drugs by global revenue 2028
- Basic Statistic Doctors in Germany from 1990 to 2022
- Premium Statistic Acute flaccid paralysis cases in Taiwan 2012-2022
- Premium Statistic Number of public hospital beds in France 2020, by sector
- Premium Statistic Export value medical equipment Indonesia 2019-2022
Related statistics
10
- Premium Statistic Claims paid by health insurers New Zealand 2010-2021
- Premium Statistic Most expensive prescription drugs Australia FY 2021, by cost to government
- Premium Statistic Number of specialized mental healthcare facilities Australia FY 2019, by type
- Premium Statistic Number of beds in private mental health hospitals Australia FY 2009-2019
- Premium Statistic Number of public sector mental health hospital beds Australia FY 2008-2019
- Premium Statistic Medical and other health care services industry employees New Zealand 2020, by region
- Premium Statistic Share of pharmaceutical sales in Australia 2018, by pharmaceutical class
- Premium Statistic Number of GPs in Australia 2019, by state and territory
- Premium Statistic Number of GPs in Australia 2019, by remoteness
- Premium Statistic Prevalence of type 2 diabetes in Australia 2017-18 by age group
Further related statistics
10
- Merck & Co total assets 2009-2023
- Leading causes of death among the white population in the United States in 2020
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- GSK's operating profit by division 2006-2021
- Leading causes of death among Black U.S. residents in 2020
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Primary reason for receiving a massage in the U.S. 2015
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Leading causes of death among the white population in the United States in 2020
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co - expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- GSK's operating profit by division 2006-2021
- Leading causes of death among Black U.S. residents in 2020
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
- Primary reason for receiving a massage in the U.S. 2015
CSL. (September 6, 2019). Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 03, 2024, from https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/
CSL. "Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars)." Chart. September 6, 2019. Statista. Accessed May 03, 2024. https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/
CSL. (2019). Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 03, 2024. https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/
CSL. "Total Current Liabilities of Csl Limited in Australia from Financial Year 2014 to 2019 (in Million U.S. Dollars)." Statista, Statista Inc., 6 Sep 2019, https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/
CSL, Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/ (last visited May 03, 2024)
Total current liabilities of CSL Limited in Australia from financial year 2014 to 2019 (in million U.S. dollars) [Graph], CSL, September 6, 2019. [Online]. Available: https://www.statista.com/statistics/1066450/australia-csl-ltd-current-liabilities/